跳至主要内容
临床试验/IRCT20160206026390N12
IRCT20160206026390N12已完成2 期

Evaluating the efficiency of alpha-lipoic acid supplementation on inflammatory biomarkers in hemodialysis patients: A double-blind placebo clinical trial

Shahrekord University of Medical Sciences0 个研究点目标入组 92 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
92

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 80 years(—)
性别
All

入选标准

  • Patients (20-80 yr.) with a history of hemodialysis treatment for a minimum of six months
  • Willing to participate in the trial

排除标准

  • -Any recent significant changes in patients' lifestyle behaviors (diet, physical activity, stress)
  • -History of consuming any antioxidant or anti-inflammatory dietary supplements less than one month before study enrollment
  • -Possible kidney transplantation
  • -History of alcohol consumption
  • -History of cigarette smoking
  • -Allergies or intolerance to alpha-lipoic acid
  • -History of cancer

研究者

相似试验